Skip to main content
Log in

Rationale for the use of 5-HT1-like agonists in the treatment of migraine

  • Migraine Therapy And 5-HT Receptor Activity
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Summary

Migraine headache is thought to be associated with a dilatation of cranial blood vessels, particularly those in the dura mater, and an accompanying localized sterile inflammatory response. Sumatriptan is a highly selective 5-HT1-like receptor agonist which selectively constricts cranial blood vessels (including those in the dura mater). It also inhibits neurogenically-mediated plasma protein extravasation in the dura mater. Haemodynamic studies in anaesthetized animals have shown that sumatriptan selectively constricts the carotid arterial circulation and this effect appears to be restricted to an effect on carotid arteriovenous anastomoses. Sumatriptan has a much more selective pharmacological profile than ergot preparations which are also used in the acute treatment of migraine. The development of sumatriptan has been based on a vascular theory of migraine and its high degree of efficacy in the treatment of migraine strengthens the argument that dilatation of cranial blood vessels is the cause of vascular headache.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Apperley E, Feniuk W, Humphrey PPA, Levy GP (1980) Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature. Br J Pharmacol 68:215–224

    Google Scholar 

  2. Bom AH, Heiligers JPC Saxena PR, Verdouw PD (1989) Reduction of cephalic arteriovenous shunting by ergotamine is not mediated by 5-HT1-like or 5-HT2 receptors. Br J Pharmacol 97:383–390

    Google Scholar 

  3. Bradley PB, Engel G, Feniuk W, Fozard JR, Humphrey PPA, Middlemiss DN, Mylecharane EJ, Richardson BP, Saxena PR (1986) Proposals for the nomenclature of functional receptors for 5-hydroxytryptamine. Neuropharmacology 25:563–576

    Google Scholar 

  4. Buzzi MG, Moskowitz MA (1990) The antimigraine drug sumatriptan (GR43175) selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 99:202–206

    Google Scholar 

  5. Connor HE, Feniuk W, Humphrey PPA (1989) Characterisation of 5-HT receptors mediating contraction of canine and primate basilar artery using GR43175 a selective 5-HT1-like receptor agonist. Br J Pharmacol 96:379–387

    Google Scholar 

  6. Conti A, Monopoli A, Forlani A, Ongini E, Antona C, Biglioli P (1990) Role of 5-HT2 receptors in serotonin-induced contraction in the human mammary artery. Eur J Pharmacol 176:207–212

    Google Scholar 

  7. Dallas FAA, Dixon CM, McCulloch RJ, Saynor DA (1989) The kinetics of14C-GR43175 in rat and dog. Cephalalgia 9 (suppl 9):53–56

    Google Scholar 

  8. Den Boer MO, Villalón CM, Heiligers JPC, Humphrey PPA, Saxena PR (1991) Role of 5-HT1-like receptors in the reduction of porcine cranial arteriovenous anastomotic shunting by sumatriptan. Br J Pharmacol (in press)

  9. Fay T (1932) Atypical facial neuralgia, a syndrome of vascular pain. Ann Otol Rhinol Laryngol 41:1030–1062

    Google Scholar 

  10. Feniuk W, Humphrey PPA (1989) Mechanisms of 5-hydroxytryptamine-induced vasoconstriction. In: Fozard JR (ed) The peripheral actions of 5-hydroxytryptamine. Oxford University Press, Oxford, pp 100–122

    Google Scholar 

  11. Feniuk W, Humphrey PPA, Perren MJ, Watts AD (1985) A comparison of 5-hydroxytryptamine receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists. Br J Pharmacol 86:697–704

    Google Scholar 

  12. Feniuk W, Humphrey PPA, Perren MJ (1989) The selective carotid arterial vasoconstrictor action of GR43175 in anaesthetised dogs. Br J Pharmacol 96:83–90

    Google Scholar 

  13. Feniuk W, Humphrey PPA, Perren MJ (1989) GR43175 does not share the complex pharmacology of the ergots. Cephalalgia 9 (suppl 9): 35–39

    Google Scholar 

  14. Graham JR, Wolff HG (1938) Mechanism of migraine headache and action of ergotamine tartrate. Arch Neurol Psychiatry 39:737–763

    Google Scholar 

  15. Heyck H (1969) Pathogenesis of migraine. Res Clin Stud Headache 2:1–28

    Google Scholar 

  16. Humphrey PPA (1991) 5-Hydroxytryptamine and the pathophysiology of migraine. J Neurol 238 (suppl 1):S38-S44

    Google Scholar 

  17. Humphrey PPA, Feniuk W, Perren MJ, Connor HE, Oxford AW, Coates IH, Butina D (1988) GR43175 a selective agonist for the 5-HT1-like receptor in dog isolated saphenous vein. Br J Pharmacol 94:1123–1132

    Google Scholar 

  18. Humphrey PPA, Feniuk W, Perren MJ, Connor HE, Oxford AW (1989) The pharmacology of the novel 5-HT1-like receptor agonist GR43175. Cephalalgia 9 (suppl 9):63–72

    Google Scholar 

  19. Humphrey PPA, Feniuk W, Perren MJ, Skingle M, Beresford IJM, Whalley ET (1989) Further studies on the mechanism of the antimigraine action of sumatriptan. Cephalalgia 9 (suppl 10):361–362

    Google Scholar 

  20. Jansen I, Tfelt-Hansen P, Edvinsson L (1985) Comparison of the vasomotor effects of the calcium entry blocker flunarizine and nimodipine in human cerebral and temporal arteries. Cephalalgia 5 (suppl 3):206–207

    Google Scholar 

  21. Kerber CW, Newton TH (1973) The macro and microvasculature of the dura mater. Neuroradiology 6:175–179

    Google Scholar 

  22. Kimball RW, Friedman AP, Vallejo E (1960) Effect of serotonin in migraine patients. Neurology 10:107–111

    Google Scholar 

  23. Lance JW, Anthony M, Hinterberger H (1967) The control of cranial arteries by humoral mechanisms and its relation to the migraine syndrome. Headache 7:93–102

    Google Scholar 

  24. Lance JW, Lambert GA, Goadsby PJ, Zagoni A (1989) 5-Hydroxytryptamine and its putative aetiological involvement in migraine. Cephalalgia 9 (suppl 9):7–13

    Google Scholar 

  25. McCarthey BG, Peroutka SJ (1989) Comparative neuropharmacology of dihydroergotamine and sumatriptan (GR43175). Headache 29:420–422

    Google Scholar 

  26. Moskowitz MA (1984) The neurobiology of vascular head pain. Ann Neurol 16:157–168

    Google Scholar 

  27. Moskowitz MA, Buzzi MG (1991) Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions. J Neurol 238 (suppl 1):S18-S22

    Google Scholar 

  28. Nichols FT, Mawad M, Mohr JP, Stein B, Hilal S, Michelsen WJ (1990) Focal headache during balloon inflation in the internal carotid and middle cerebral arteries. Stroke 21:555–559

    Google Scholar 

  29. Parsons AA, Whalley ET, Feniuk W, Connor HE, Humphrey PPA (1989) 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of human isolated basilar artery. Br J Pharmacol 96:434–440

    Google Scholar 

  30. Penfield W (1935) A contribution to the mechanism of intracranial pain. Assoc Res Neuro Ment Dis 15:399–416

    Google Scholar 

  31. Perren MJ, Feniuk W, Humphrey PPA (1989) The selective closure of feline carotid arteriovenous anastomoses (AVAs) by GR43175. Cephalalgia 9 (suppl 9):41–46

    Google Scholar 

  32. Perren MJ, Feniuk W, Humphrey PPA (1991) Vascular 5-HT1-like receptors which mediate contraction of the dog isolated saphenous vein and carotid arterial vasoconstriction in anaesthetised dogs are not of the 5-HT1A or 5-HT1D subtype. Br J Pharmacol 102:191–197

    Google Scholar 

  33. Perrin VL, Färkhilä M, Goasguen J, Doenicke A, Brand J, Tfelt-Hansen P (1989) Overview of initial clinical studies with intravenous and oral GR43175 in acute migraine. Cephalalia 9 (suppl 9):63–72

    Google Scholar 

  34. Ray BS, Wolff HG (1940) Experimental studies on headache. Pain sensitive structures of the head and their significance in headache. Arch Surg 41:813–856

    Google Scholar 

  35. Rowbotham GF, Little E (1965) New concepts on the aetiology and vascularisation of meningiomater; the mechanisms of migraine; the chemical process of the cerebrospinal fluid; and the formations of the collections of fluid in the subdural space. Br J Surg 52:21–24

    Google Scholar 

  36. Saxena PR (1972) The effects of antimigraine drugs on the vascular responses evoked by 5-hydroxytryptamine and related biogenic substances on the external carotid bed of dogs: possible pharmacological implications to their antimigraine action. Headache 12:44–54

    Google Scholar 

  37. Saxena PR (1974) Selective vasoconstriction in carotid vascular bed, by methysergide: possible relevance to its antimigraine effect. Eur J Pharmacol 27:99–105

    Google Scholar 

  38. Saxena PR (1987) The arteriovenous anastomoses and veins in migraine research. In: Blau JN (ed) Migraine — therapeutic, conceptual and research aspects. Elsevier, Amsterdam, pp 581–596

    Google Scholar 

  39. Saxena PR, Verdouw PD (1982) Redistribution by 5-hydroxytryptamine of carotid arterial blood at the expense of arteriovenous anastomotic blood flow. J Physiol (Lond) 332:501–520

    Google Scholar 

  40. Saxena PR, de Vlaam-Schluter GM (1974) Role of some biogenic substances in migraine and relevant mechanisms in antimigraine action of ergotamine. Studies in an experimental model for migraine. Headache 13:142–163

    Google Scholar 

  41. Toda N, Fujita Y (1973) Responsiveness of isolated cerebral and peripheral arteries to serotonin, norepinephrine and transmural electrical stimulation. Circ Res 33:98–103

    Google Scholar 

  42. Van Wijngaarden I, Tulp MTLM, Soudjin W (1990) The concept of selectivity in 5-HT receptor research. Eur J Pharmacol (Molec Pharmacol Sect) 188:301–312

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feniuk, W., Humphrey, P.P.A., Perren, M.J. et al. Rationale for the use of 5-HT1-like agonists in the treatment of migraine. J Neurol 238 (Suppl 1), S57–S61 (1991). https://doi.org/10.1007/BF01642908

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01642908

Key words

Navigation